BHK Investment Advisors’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,305
Closed -$49.7K 55
2023
Q3
$49.7K Sell
2,305
-1,078
-32% -$42.3K 0.02% 54
2023
Q2
$228K Sell
3,383
-29
-0.8% -$12K 0.1% 58
2023
Q1
$1.59M Sell
3,412
-90
-3% -$47.6K 0.7% 19
2022
Q4
$1.4M Buy
3,502
+4
+0.1% +$1.53K 0.79% 19
2022
Q3
$1.14M Hold
3,498
0.57% 21
2022
Q2
$923K Buy
3,498
+1,080
+45% +$276K 0.42% 27
2022
Q1
$727K Buy
2,418
+16
+0.7% +$5.58K 0.3% 28
2021
Q4
$847K Sell
2,402
-410
-15% -$128K 0.33% 27
2021
Q3
$718K Buy
2,812
+1,008
+56% +$357K 0.3% 28
2021
Q2
$1.2M Buy
1,804
+290
+19% +$167K 0.49% 25
2021
Q1
$1.4M Buy
1,514
+6
+0.4% +$6.39K 0.65% 20
2020
Q4
$1.4M Buy
1,508
+6
+0.4% +$6.31K 0.65% 20
2020
Q3
$1.54M Sell
1,502
-32
-2% -$34.4K 0.87% 18
2020
Q2
$1.55M Buy
1,534
+44
+3% +$40.9K 0.92% 18
2020
Q1
$1.29M Buy
1,490
+358
+32% +$356K 0.92% 18
2019
Q4
$1.21M Buy
1,132
+62
+6% +$63.3K 0.69% 22
2019
Q3
$989K Buy
1,070
+132
+14% +$145K 0.57% 34
2019
Q2
$1.06M Buy
938
+132
+16% +$144K 0.6% 32
2019
Q1
$1.09M Buy
806
+82
+11% +$111K 0.66% 28
2018
Q4
$838K Buy
724
+122
+20% +$137K 0.63% 25
2018
Q3
$914K Hold
602
0.62% 24
2018
Q2
$942K Buy
602
+29
+5% +$37.8K 0.66% 23
2018
Q1
$662K Buy
573
+21
+4% +$27.7K 0.49% 25
2017
Q4
$654K Buy
+552
New +$692K 0.55% 23

Other funds holding KYNB

BHK Investment Advisors's KYNB Position: Q4 2023 in Review

BHK Investment Advisors sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 2,305 shares — an estimated $49.7K sold.

BHK Investment Advisors first reported a position in KYNB in Q4 2017 and held it in 24 quarters. The position peaked at $1.59M in Q1 2023. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • BHK Investment Advisors reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • BHK Investment Advisors sold 2,305 Kyntra Bio shares in Q4 2023, an estimated $49.7K.
  • BHK Investment Advisors first reported a position in Kyntra Bio in Q4 2017 and held it in 24 quarters.
  • BHK Investment Advisors's Kyntra Bio position peaked at $1.59M in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on BHK Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.